Skip to main content
. 2022 May 24;66(6):e00132-22. doi: 10.1128/aac.00132-22

TABLE 3.

Antitubercular drug activity against selected GSK2556286-resistant M. tuberculosis strains infecting THP-1 cells

Compound Activity against M. tuberculosis strainc
EM19a EM33b
Isoniazid 0.57 0.54
Rifampicin 0.77 0.47
Moxifloxacin 0.32 0.30
a

cya mutation confirmed.

b

The presence or absence of a cya mutation remains to be confirmed.

c

Activity is presented as the ratio of the IC50 of the mutant/IC50 of wild-type EM01.